Loss of PI3 kinase association improves the sensitivity of secondary mutation of KIT to Imatinib

被引：0
|
作者：
Guangrong Zhu
Jun Shi
Shaoting Zhang
Yue Guo
Ling Huang
Hui Zhao
Yideng Jiang
Jianmin Sun
机构：
[1] Ningxia Medical University,School of Basic Medical Sciences
[2] The Chinese University of Hong Kong,Key Laboratory for Regenerative Medicine, Ministry of Education, School of Biomedical Sciences, Faculty of Medicine
[3] Chinese Academy of Sciences-The Chinese University of Hong Kong Joint Laboratory of Bioresources and Molecular Research of Common Diseases,Kunming Institute of Zoology
[4] NHC Key Laboratory of Metabolic Cardiovascular Diseases Research (Ningxia Medical University),Division of Translational Cancer Research, Lund Stem Cell Center, Department of Laboratory Medicine
[5] Ningxia Key Laboratory of Vascular Injury and Repair Research,undefined
[6] Lund University,undefined
来源：
Cell & Bioscience | / 10卷
关键词：
KIT; GISTs; PI3 kinase; Imatinib; Drug resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner
    Oscar Lindblad
    Julhash U. Kazi
    Lars Rönnstrand
    Jianmin Sun
    Cellular and Molecular Life Sciences, 2015, 72 : 4399 - 4407
  • [42] The role of PI3 kinase pathway in the the skin of Sezary syndrome
    Cristofoletti, Cristina
    Bresin, Antonella
    Picozza, Mario
    Picchio, Maria Cristina
    Passarelli, Francesca
    Monzo, Francesca
    Citterich, Mauro Helmer
    Monopoli, Alessandro
    Benucci, Roberto
    Cantonetti, Maria
    Frezzolini, Alessandra
    Scala, Enrico
    Caprini, Elisabetta
    Russo, Giandomenico
    Narducci, Maria Grazia
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Should individual PI3 kinase isoforms be targeted in cancer?
    Jia, Shidong
    Roberts, Thomas M.
    Zhao, Jean J.
    CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) : 199 - 208
  • [44] Inhibition of PI3 Kinase Gamma Enzyme by Novel Phenylpyrazoles
    Bepary, Sukumar
    Youn, In Kwon
    Lim, Hee-Jong
    Lee, Ge Hyeong
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2013, 34 (09): : 2829 - 2832
  • [45] A Mechanism for Synergy with Combined mTOR and PI3 Kinase Inhibitors
    Yang, Shujie
    Xiao, Xue
    Meng, Xiangbing
    Leslie, Kimberly K.
    PLOS ONE, 2011, 6 (10):
  • [46] PI3 Kinase Isoforms in Purinergic Mesenchymal Stromal Cells
    Kotova, P. D.
    Bystrova, M. F.
    BIOLOGICHESKIE MEMBRANY, 2020, 37 (02): : 156 - 160
  • [47] Evolution of a series of potent and efficacious PI3 kinase inhibitors
    Heffron, Timothy P.
    Berry, Megan
    Castanedo, Georgette
    Chang, Christine
    Chuckowree, Irina
    Dotson, Jennafer
    Folkes, Adrian
    Gunzner, Janet
    Lesnick, John
    Lewis, Cristina
    Malesky, Kimberly
    Mathieu, Simon
    Nonomiya, Jim
    Olivero, Alan
    Pang, Jodie
    Peterson, David
    Salphati, Laurent
    Sampath, Deepak
    Sutherlin, Daniel P.
    Tsui, Vickie
    Ultsch, Mark
    Wan, Nan Chi
    Wang, Shumei
    Wiesmann, Christian
    Wong, Susan
    Zhu, Bing-yan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [48] Galectin-1 modulates PI3 kinase activity
    Perry, James
    Chakravarti, Arnab
    Lautenschlaeger, Tim
    CANCER RESEARCH, 2010, 70
  • [49] PI3 kinase pathway during resistance to trastuzumab (Herception®)
    Darbon, Jean-Marie
    BULLETIN DU CANCER, 2008, 95 (03) : 268 - 268
  • [50] Killing Tumors by Keeping Ras and PI3′ Kinase Apart
    Yuan, Tina L.
    McCormick, Frank
    CANCER CELL, 2013, 24 (05) : 562 - 563
12345